The Lean Startup Academy is an unique opportunity to mature your business by systematically testing your ideas against the market with the support of experts. The course will help you to identify who your prioritary customers should be initially, what is the right value proposition for them and how to reach them. 
At this year's Internationale Funkausstellung (IFA) in Berlin, Germany, Royal Philips (NYSE: PHG, AEX: PHIA) showcases new products and services that empower consumers to take an active role in managing their health and well-being to get the most out of life. Philips' highlights at the exhibition include innovations in sleep therapy, mother and child care, air quality, oral health and female beauty. 
The ambitions of NHS Digital’s e-nursing week and the Royal College of Nursing's (RCN) 'Every nurse an e-nurse' campaign are being realised by nurses across the UK, who are seeing the benefits of using digital health on the frontline by using Patientrack, a technology used by nursing staff to capture patient vital signs and alert doctors when urgent attention is needed, Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has announced the continued momentum of its cutting-edge pathology diagnostics with the successful transformation of two fully digital pathology labs in Austria. The Pathology Institute in Hall and the Pathology Institute at Tirol Kliniken Innsbruck have fully digitized their diagnostic process with Philips IntelliSite Pathology Solution, 
VTT Technical Research Centre of Finland studied the implementation of a logistics robot system at the Seinäjoki Central Hospital in South Ostrobothnia. The aim is to reduce transportation costs, improve the availability of supplies and alleviate congestion on hospital hallways by running deliveries around the clock on every day of the week. 
Allscripts (NASDAQ:MDRX) has partnered with Elligo Health Research to assist clinicians to conduct clinical trial studies in their own clinics. Through the Allscripts / Elligo partnership, clinical trials managed by Clinical Research Organizations (CROs) will be available, bringing new treatments to patients across major therapeutic areas. Royal Philips (NYSE: PHG, AEX: PHIA) and HeartFlow, Inc. announced today that they have entered into a collaboration agreement with the goal of improving access to diagnostic and planning tools for interventional cardiologists evaluating and treating patients with suspected coronary artery disease (CAD). Under the agreement, Philips will promote the use of the